EG18563A - Process for preparing of dihydropyridines useful in the treatment and inflammatory conditions - Google Patents

Process for preparing of dihydropyridines useful in the treatment and inflammatory conditions

Info

Publication number
EG18563A
EG18563A EG499/88A EG49988A EG18563A EG 18563 A EG18563 A EG 18563A EG 499/88 A EG499/88 A EG 499/88A EG 49988 A EG49988 A EG 49988A EG 18563 A EG18563 A EG 18563A
Authority
EG
Egypt
Prior art keywords
preparing
treatment
inflammatory conditions
dihydropyridines
useful
Prior art date
Application number
EG499/88A
Other languages
English (en)
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878722977A external-priority patent/GB8722977D0/en
Priority claimed from GB888804441A external-priority patent/GB8804441D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Application granted granted Critical
Publication of EG18563A publication Critical patent/EG18563A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
EG499/88A 1987-09-30 1988-09-29 Process for preparing of dihydropyridines useful in the treatment and inflammatory conditions EG18563A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878722977A GB8722977D0 (en) 1987-09-30 1987-09-30 Therapeutic agents
GB888804441A GB8804441D0 (en) 1988-02-25 1988-02-25 Therapeutic agents

Publications (1)

Publication Number Publication Date
EG18563A true EG18563A (en) 1993-08-30

Family

ID=26292797

Family Applications (1)

Application Number Title Priority Date Filing Date
EG499/88A EG18563A (en) 1987-09-30 1988-09-29 Process for preparing of dihydropyridines useful in the treatment and inflammatory conditions

Country Status (26)

Country Link
US (3) US4935430A (no)
EP (1) EP0310386B1 (no)
JP (2) JP2660016B2 (no)
KR (1) KR900008318B1 (no)
CN (1) CN1032648C (no)
AU (2) AU597190B2 (no)
CA (1) CA1340785C (no)
CY (1) CY1722A (no)
DE (1) DE3866077D1 (no)
DK (1) DK170376B1 (no)
EG (1) EG18563A (no)
ES (1) ES2038766T3 (no)
FI (1) FI93444C (no)
GR (1) GR3003468T3 (no)
HK (1) HK66093A (no)
HU (1) HU201061B (no)
IE (1) IE61045B1 (no)
IL (1) IL101332A0 (no)
MY (1) MY104933A (no)
NO (1) NO168107C (no)
NZ (1) NZ226397A (no)
PH (1) PH26046A (no)
PL (1) PL157186B1 (no)
PT (1) PT88614B (no)
SG (1) SG49393G (no)
YU (1) YU46698B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906324D0 (en) * 1989-03-20 1989-05-04 Pfizer Ltd 1,4-dihydropyridines
US4990518A (en) * 1989-09-13 1991-02-05 G. D. Searle & Co. Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines
GB9010404D0 (en) * 1990-05-09 1990-06-27 Pfizer Ltd Therapeutic agents
GB9015524D0 (en) * 1990-07-13 1990-08-29 Pfizer Ltd Therapeutic agents
GB9019409D0 (en) * 1990-09-05 1990-10-17 Pfizer Ltd Therapeutic agents
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
US5288866A (en) * 1991-12-20 1994-02-22 American Cyanamid Company 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
BR9910864A (pt) * 1998-06-04 2002-02-05 Abbott Lab Compostos anti-inflamatórios para inibição de aderência celular
EP1181296A1 (en) * 1999-06-03 2002-02-27 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
US6555543B2 (en) * 2000-08-04 2003-04-29 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
KR20150080004A (ko) 2003-05-15 2015-07-08 앰피오 파마슈티컬스 인코퍼레이티드 Ｔ-세포 매개성 질환의 치료 방법
CN113999167B (zh) * 2021-10-18 2023-09-29 蚌埠中实化学技术有限公司 一种4-氯-2,6-二甲基-3-硝基吡啶的制备方法
CN117568743B (zh) * 2024-01-15 2024-03-19 江苏普坦科金属科技有限公司 一种铁基材料的表面耐腐蚀耐磨处理工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
US4317909A (en) * 1980-03-24 1982-03-02 Sterling Drug Inc. Preparation of 1,3-dihydro-5-(pyridinyl)-2H-imidazo[4,5-b]pyridin-2-ones
US4353905A (en) 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3363743D1 (en) 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8620880D0 (en) * 1986-08-29 1986-10-08 Pfizer Ltd Therapeutic agents
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
NO874194L (no) * 1986-11-07 1988-05-09 Pfizer Ltd Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
US4820842A (en) * 1986-11-19 1989-04-11 Warner-Lambert Company 2-substituted-1,4-dihydropyridines
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
GB8803963D0 (en) * 1988-02-19 1988-03-23 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HK66093A (en) 1993-07-16
ES2038766T3 (es) 1993-08-01
HU201061B (en) 1990-09-28
EP0310386B1 (en) 1991-11-06
SG49393G (en) 1993-07-09
NO168107B (no) 1991-10-07
CY1722A (en) 1994-05-06
KR900008318B1 (ko) 1990-11-12
NO884333L (no) 1989-03-31
MY104933A (en) 1994-07-30
NO168107C (no) 1992-01-15
PH26046A (en) 1992-01-29
JPH09315973A (ja) 1997-12-09
PL157186B1 (pl) 1992-05-29
EP0310386A2 (en) 1989-04-05
CN1032648C (zh) 1996-08-28
NO884333D0 (no) 1988-09-29
JP2660016B2 (ja) 1997-10-08
DK544588D0 (da) 1988-09-29
NZ226397A (en) 1990-11-27
PT88614A (pt) 1989-07-31
GR3003468T3 (en) 1993-02-17
JP2898256B2 (ja) 1999-05-31
DE3866077D1 (de) 1991-12-12
PL274977A1 (en) 1989-08-21
AU6126190A (en) 1990-11-29
IE61045B1 (en) 1994-09-07
IL101332A0 (en) 1992-11-15
EP0310386A3 (en) 1989-11-15
AU617256B2 (en) 1991-11-21
AU2297388A (en) 1989-04-06
DK544588A (da) 1989-05-11
DK170376B1 (da) 1995-08-14
KR890005054A (ko) 1989-05-11
FI93444B (fi) 1994-12-30
JPH01113367A (ja) 1989-05-02
CN1032439A (zh) 1989-04-19
AU597190B2 (en) 1990-05-24
CA1340785C (en) 1999-10-12
HUT48872A (en) 1989-07-28
FI884471A (fi) 1989-03-31
US5063237A (en) 1991-11-05
PT88614B (pt) 1993-07-30
IE882944L (en) 1989-03-30
FI884471A0 (fi) 1988-09-29
YU182088A (en) 1990-06-30
FI93444C (fi) 1995-04-10
US5120747A (en) 1992-06-09
YU46698B (sh) 1994-04-05
US4935430A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
PT84533A (en) Process for preparing oxadiazoles useful in the treatment of senile dementia
GB2210132B (en) Floodwashing process and floodwasher
HUT65318A (en) Beta-sitostanol-fatty-acid-esters lowering of cholesterol-level in serum and process for the production of these
YU11988A (en) Process for obtaining b avermectines and their derivatives
HUT51848A (en) Process for conservation of transpantable epitheliumshives produced in vitro
EG18563A (en) Process for preparing of dihydropyridines useful in the treatment and inflammatory conditions
EP0336977A4 (en) Semiconducteur device and method of producing the same
EP0281420A3 (en) High strength porcelains for use in insulators and production thereof
DE3760920D1 (en) Process and apparatus for the production of nitrogen
PT86082A (en) Process for preparing dihydropyridine anti-allergic and anti-inflamatory agents
HU886790D0 (en) Neutrophilous activating factor and process for its preparation
EP0312825A3 (en) Polymeric hydridochlorosilazanes and process for their preparation
HU885829D0 (en) Process for the preparation of pyrroloquinoline and pyrrolophenothiazine carboxamide derivatives
GB9019107D0 (en) Improvements in or relating to methods of and apparatus for the manufacture of confectionery
EP0306841A3 (en) Mold surface treatment process and mold
IL87743A0 (en) Process for the preparation of superconductors and products obtained thereby
HUT53381A (en) Light-stabilizing akryl-polimers and process for their production
HUT47258A (en) Process for production of tetrasole-derivatives decreasing the pathalogically high colestherin-level of blood and intermediers applicable for their production
EP0486946A3 (en) Process for the production of metallopolysilanes and their use
PH24676A (en) Use of mini-somatostatin in the treatment of senile dementia
EP0312922A3 (en) Oxethylsulfonyl-nitro- or -amino-benzoic acids and process for their preparation
ZA889130B (en) Compositions for the reduction of phlebectasiae and process for preparing same
EP0296479A3 (en) Fluorobenzoates and process for their production
DE3571616D1 (en) 5-halo-4h-1,3-dioxin-4-one compounds, process for their preparation and their use in the preparation of alpha-halo-acetoacetic esters
EP0310944A3 (en) Bisoxethylsulfonylmethyl anilines and process for their preparation